- Home
- PRQR vs TONX Comparison
PRQR vs TONX Comparison
Compare PRQR & TONX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRQR
- TONX
- Stock Information
- Founded
- PRQR 2012
- TONX N/A
- Country
- PRQR Netherlands
- TONX United States
- Employees
- PRQR N/A
- TONX N/A
- Industry
- PRQR Biotechnology: Pharmaceutical Preparations
- TONX Other Consumer Services
- Sector
- PRQR Health Care
- TONX Consumer Discretionary
- Exchange
- PRQR Nasdaq
- TONX Nasdaq
- Market Cap
- PRQR 224.4M
- TONX 248.4M
- IPO Year
- PRQR 2014
- TONX N/A
- Fundamental
- Price
- PRQR $2.80
- TONX $4.02
- Analyst Decision
- PRQR Strong Buy
- TONX
- Analyst Count
- PRQR 8
- TONX 0
- Target Price
- PRQR $8.88
- TONX N/A
- AVG Volume (30 Days)
- PRQR 649.8K
- TONX 798.3K
- Earning Date
- PRQR 11-07-2025
- TONX 11-14-2025
- Dividend Yield
- PRQR N/A
- TONX N/A
- EPS Growth
- PRQR N/A
- TONX N/A
- EPS
- PRQR N/A
- TONX N/A
- Revenue
- PRQR $20,129,184.00
- TONX $4,279,000.00
- Revenue This Year
- PRQR N/A
- TONX $526.82
- Revenue Next Year
- PRQR N/A
- TONX $45.45
- P/E Ratio
- PRQR N/A
- TONX N/A
- Revenue Growth
- PRQR 8.65
- TONX 4095.10
- 52 Week Low
- PRQR $1.07
- TONX $3.46
- 52 Week High
- PRQR $4.21
- TONX $13.90
- Technical
- Relative Strength Index (RSI)
- PRQR 60.30
- TONX N/A
- Support Level
- PRQR $2.71
- TONX N/A
- Resistance Level
- PRQR $3.00
- TONX N/A
- Average True Range (ATR)
- PRQR 0.24
- TONX 0.00
- MACD
- PRQR 0.01
- TONX 0.00
- Stochastic Oscillator
- PRQR 71.11
- TONX 0.00
About PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About TONX TON Strategy Company Common Stock
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.